1492 Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.71M Sell
324,019
-846
-0.3% -$17K 2.17% 10
2025
Q4
$6.42M Buy
324,865
+124,143
+62% +$2.23M 2.46% 9
2025
Q3
$3.5M Buy
200,722
+114,622
+133% +$1.7M 1.42% 27
2025
Q2
$1.21M Sell
86,100
-22,583
-21% -$364K 0.56% 64
2025
Q1
$2.02M Buy
108,683
+13
+0% +$194 1.09% 35
2024
Q4
$1.22M Buy
108,670
+36,755
+51% +$430K 0.58% 54
2024
Q3
$850K Buy
+71,915
New +$680K 0.42% 53

Other funds holding ALHC

1492 Capital Management's ALHC Position: Q1 2026 in Review

1492 Capital Management reduced its Alignment Healthcare (ALHC) stake by 0.26% in Q1 2026, selling an estimated $17K and leaving 324,019 shares worth $5.71M. The position accounts for 2.17% of the portfolio, ranked #10.

1492 Capital Management first reported a position in ALHC in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.42M in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • 1492 Capital Management held 324,019 shares of Alignment Healthcare worth $5.71M as of Q1 2026.
  • 1492 Capital Management sold 846 Alignment Healthcare shares in Q1 2026, an estimated $17K.
  • Alignment Healthcare made up 2.17% of 1492 Capital Management's portfolio in Q1 2026, its #10 holding.
  • 1492 Capital Management first reported a position in Alignment Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 1492 Capital Management's Alignment Healthcare position peaked at $6.42M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on 1492 Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.